Lexology July 3, 2024
McDermott Will & Emery

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker, a subscription product from McDermott+Consulting.

Issues at Stake: Contract Pharmacy

  • Two drug manufacturers filed three separate complaints against two state attorneys general to challenge...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Insurance, Pharma, Pharma / Biotech, Provider
Related Articles:
Drug prohibition is fueling the overdose crisis: Regulating drugs is the way out
How Ozempic could save America's health system
Opinion: First Opinion readers respond to psychiatry and social contracts, Medicare and weight loss meds, and more
Diabetes drugs like Ozempic lower cancer risks: Study
STAT+: GLP-1s lower risk of 10 obesity-associated cancers, study shows

Share This Article